A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer
Titel:
A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer
Auteur:
Tabernero, J. Climent, M.A. Lluch, A. Albanell, J. Vermorken, J.B. Barnadas, A. AntoĢn, A. Laurent, C. Mayordomo, J.I. Estaun, N. Losa, I. Guillem, V. Garcia-Conde, J. Tisaire, J.L. Baselga, J.